Skip to main content

Table 2 Baseline medications

From: Risk stratification and mortality prediction in octo- and nonagenarians with peripheral artery disease: a retrospective analysis

 

 ≥ 80 years old (n = 123)

 < 80 years old (n = 123)

 

Antiplatelet therapy

82 (67%)

110 (90%)

0.0001

VKA

15 (12%)

10 (8%)

0.0001

DOACs

28 (23%)

2 (2%)

0.0001

Statin therapy

79 (64%)

95 (77%)

0.035

ACE- inhibitor

57 (46%)

64 (52%)

0.444

AT-II-receptor antagonist

31 (25%)

34 (28%)

0.773

Beta-blockers

73 (60%)

80 (65%)

0.430

Calcium channel blockers

47 (38%)

47 (38%)

1

Aldosterone antagonists

18 (15%)

13 (11%)

0.443

Thiazides

35 (28%)

30 (24%)

0.563

Loop diuretics

55 (45%)

35 (28%)

0.008

  1. VKA, Vitamin K antagonists; DOACs, Directs oral anticoagulants; ACE, angiotensin converting enzyme